Voltarol Max Strength Pain Relief 2.32% Gel

Voltarol is a prominent brand of topical pain relief, containing the active ingredient diclofenac diethylammonium. Originally developed within the pharmaceutical landscape of Switzerland, it has become a household name for treating joint and muscle inflammation. The brand is a variation of the globally recognized Voltaren name, specifically marketed as Voltarol in the United Kingdom and Ireland.

The product is manufactured in several locations globally to meet local demand; however, a significant portion of the supply for the European market is produced in Germany and Switzerland. The packaging shown features the 'P' classification, indicating it is a pharmacy-grade medicine in the UK market.

Historically, the brand was part of Novartis. Following a major joint venture and subsequent demerger in 2022, the brand is now owned by Haleon. Haleon is a world-leading consumer healthcare company headquartered in the United Kingdom, which oversees a vast portfolio of wellness and pain management brands. This transition marked one of the largest corporate reorganizations in the pharmaceutical sector, establishing Haleon as a standalone entity focused entirely on consumer health products.